Eyelid sebaceous carcinoma

Eyelid sebaceous carcinoma (also known as sebaceous gland carcinoma of the eyelid, meibomian gland carcinoma, or sebaceous cell carcinoma of the ocular adnexa) is a rare but aggressive malignant tumor arising from the sebaceous glands of the eyelid, most commonly the meibomian glands in the tarsal plate, but also from the glands of Zeis, or sebaceous glands of the caruncle and eyebrow. It is the second most common malignant eyelid tumor after basal cell carcinoma in some populations, though it remains relatively rare overall. The tumor primarily affects the ocular and periocular region and can present as a firm, painless nodule on the upper or lower eyelid, often mimicking benign conditions such as chalazion or chronic blepharoconjunctivitis, which frequently leads to delayed diagnosis. Key clinical features include a slowly enlarging eyelid mass, loss of eyelashes (madarosis), thickening of the eyelid, chronic unilateral blepharoconjunctivitis, and yellowish discoloration of the affected area due to the lipid-rich nature of the tumor. The disease can exhibit pagetoid spread, where tumor cells spread along the conjunctival epithelium, making it particularly challenging to manage. Regional lymph node metastasis and distant metastasis to organs such as the lungs, liver, and brain can occur, particularly in advanced or recurrent cases. Eyelid sebaceous carcinoma is more common in older adults, with a peak incidence in the sixth to seventh decades of life, and has a higher prevalence among Asian populations. Treatment typically involves wide local surgical excision with histologically confirmed clear margins, often using Mohs micrographic surgery or frozen section control to ensure complete removal. In cases with extensive pagetoid spread or orbital invasion, orbital exenteration may be necessary. Sentinel lymph node biopsy may be performed to assess regional spread. Adjuvant therapies including cryotherapy, topical mitomycin C for conjunctival pagetoid disease, and radiation therapy may be used in select cases. Patients with Muir-Torre syndrome, a variant of Lynch syndrome caused by germline mutations in mismatch repair genes (particularly MSH2 and MLH1), have an increased risk of developing sebaceous carcinomas, including those of the eyelid, and should be evaluated for this hereditary cancer predisposition. Prognosis depends on tumor size, stage, and the presence of pagetoid spread or metastasis, with early detection and complete excision offering the best outcomes.

Common questions about Eyelid sebaceous carcinoma